Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Efficient Treatment of Psoriasis Using Conditioned Media from Mesenchymal Stem Cell Spheroids Cultured to Produce Transforming Growth Factor-β1-Enriched Small-Sized Extracellular Vesicles

October 2024 Bioprinting, Bioprocessing, Blood, Cell Therapy, Dermal and Wound, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Functional high capacity exosome-encapsulating bioinspired hydrogel promotes microvascular bed expansion in diabetic mice

August 2024 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Clinical, Dermal and Wound, Diabetes, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

An Exosome-Laden Hydrogel Wound Dressing That Can Be Point-of-Need Manufactured in Austere and Operational Environments

August 2024 Bioprinting, Bioprocessing, Cell Therapy, Dermal and Wound, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Tissue Engineering

Innovative Platforms for Macrophage Behavior: Establishment of Stable Macrophage Reporters And Macrophage-Incorporated Airway Organoid

July 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Dermal and Wound, Gene Editing, Immunomodulation, Lung, Tissue Engineering

Bioprocess Design and Optimization for Extracellular Vesicles Derived from Mesenchymal Stem Cells

June 2024 Bioprocessing, Cell Therapy, Clinical, Dermal and Wound, Exosomes / Extracellular Vesicles

Hypoxia Priming as a Minimal Manipulation Strategy to Enhance the Regenerative & Immunomodulatory Properties of MSC Derived Small Extracellular Vesicles

June 2024 Bioprocessing, Cell Therapy, Dermal and Wound, Exosomes / Extracellular Vesicles, Immunomodulation, Orthopedic

Significant Enhancement of Fibroblast Migration, Invasion, and Proliferation by Exosomes Loaded with Human Fibroblast Growth Factor 1

January 2024 Cancer, Cell Therapy, Dermal and Wound, Exosomes / Extracellular Vesicles, Immunomodulation

Subcutaneous White Adipose Tissue Independently Regulates Burn-induced Hypermetabolism Via Immune-adipose Crosstalk

December 2023 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Dermal and Wound, Immunomodulation, Tissue Engineering

Fertility Protection, a Novel Concept: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Protect Against Chemotherapy-induced Testicular Cytotoxicity

December 2023 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Dermal and Wound, Immunomodulation, Tissue Engineering

Progress on Electro-Enhancement of Cell Manufacturing

December 2023 Cancer, Cell Therapy, Clinical, Dermal and Wound
Previous 1 2 3 4 5 6 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email